Choose a language and wait for the translated text.
In its first phase, the facility will manufacture oral solid dosage forms for the Sri Lankan market and is projected to begun commercial operations in 2028.
Zydus to set up $20 million manufacturing facility in Sri Lanka | PharmaVoice
